One of the penny stocks to watch due to its recent performance is that of Capricor Therapeutics Inc (CAPR Stock Report). Back on September 24, the company had been granted a meeting by the United States Food and Drug Administration.
"Shares gained as much as 20% as Capricor stock started the week with a bang. It is one of the biotech penny stocks that have performed impressively over recent days. Obviously with news like this and the type of momentum CAPR stock is seeing, many will have it on their watch lists for the week. "
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.